237 related articles for article (PubMed ID: 26846400)
1. Spinocerebellar ataxia type 2: Measures of saccade changes improve power for clinical trials.
Rodríguez-Labrada R; Velázquez-Pérez L; Auburger G; Ziemann U; Canales-Ochoa N; Medrano-Montero J; Vázquez-Mojena Y; González-Zaldivar Y
Mov Disord; 2016 Apr; 31(4):570-8. PubMed ID: 26846400
[TBL] [Abstract][Full Text] [Related]
2. Saccade velocity is reduced in presymptomatic spinocerebellar ataxia type 2.
Velázquez-Pérez L; Seifried C; Abele M; Wirjatijasa F; Rodríguez-Labrada R; Santos-Falcón N; Sánchez-Cruz G; Almaguer-Mederos L; Tejeda R; Canales-Ochoa N; Fetter M; Ziemann U; Klockgether T; Medrano-Montero J; Rodríguez-Díaz J; Laffita-Mesa JM; Auburger G
Clin Neurophysiol; 2009 Mar; 120(3):632-5. PubMed ID: 19201647
[TBL] [Abstract][Full Text] [Related]
3. Differences in saccade dynamics between spinocerebellar ataxia 2 and late-onset cerebellar ataxias.
Federighi P; Cevenini G; Dotti MT; Rosini F; Pretegiani E; Federico A; Rufa A
Brain; 2011 Mar; 134(Pt 3):879-91. PubMed ID: 21354979
[TBL] [Abstract][Full Text] [Related]
4. Saccade velocity as a surrogate disease marker in spinocerebellar ataxia type 2.
Seifried C; Velázquez-Pérez L; Santos-Falcón N; Abele M; Ziemann U; Almaguer LE; Martínez-Góngora E; Sánchez-Cruz G; Canales N; Pérez-González R; Velázquez-Manresa M; Viebahn B; Stuckrad-Barre S; Klockgether T; Fetter M; Auburger G
Ann N Y Acad Sci; 2005 Apr; 1039():524-7. PubMed ID: 15827014
[TBL] [Abstract][Full Text] [Related]
5. Eye movement abnormalities in spinocerebellar ataxia type 17 (SCA17).
Hübner J; Sprenger A; Klein C; Hagenah J; Rambold H; Zühlke C; Kömpf D; Rolfs A; Kimmig H; Helmchen C
Neurology; 2007 Sep; 69(11):1160-8. PubMed ID: 17846415
[TBL] [Abstract][Full Text] [Related]
6. Saccade velocity is controlled by polyglutamine size in spinocerebellar ataxia 2.
Velázquez-Pérez L; Seifried C; Santos-Falcón N; Abele M; Ziemann U; Almaguer LE; Martínez-Góngora E; Sánchez-Cruz G; Canales N; Pérez-González R; Velázquez-Manresa M; Viebahn B; von Stuckrad-Barre S; Fetter M; Klockgether T; Auburger G
Ann Neurol; 2004 Sep; 56(3):444-7. PubMed ID: 15349876
[TBL] [Abstract][Full Text] [Related]
7. Saccadic latency is prolonged in Spinocerebellar Ataxia type 2 and correlates with the frontal-executive dysfunctions.
Rodríguez-Labrada R; Velázquez-Pérez L; Seigfried C; Canales-Ochoa N; Auburger G; Medrano-Montero J; Sánchez-Cruz G; Aguilera-Rodríguez R; Laffita-Mesa J; Vázquez-Mojena Y; Verdecia-Ramirez M; Motta M; Quevedo-Batista Y
J Neurol Sci; 2011 Jul; 306(1-2):103-7. PubMed ID: 21481421
[TBL] [Abstract][Full Text] [Related]
8. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Kang JS; Pandolfo M; Schulz JB; Molho S; Diallo A; Klockgether T
Lancet Neurol; 2015 Nov; 14(11):1101-8. PubMed ID: 26377379
[TBL] [Abstract][Full Text] [Related]
9. Ocular motor characteristics of different subtypes of spinocerebellar ataxia: distinguishing features.
Kim JS; Kim JS; Youn J; Seo DW; Jeong Y; Kang JH; Park JH; Cho JW
Mov Disord; 2013 Aug; 28(9):1271-7. PubMed ID: 23609488
[TBL] [Abstract][Full Text] [Related]
10. Distinguishing spinocerebellar ataxia with pure cerebellar manifestation from multiple system atrophy (MSA-C) through saccade profiles.
Terao Y; Fukuda H; Tokushige SI; Inomata-Terada S; Yugeta A; Hamada M; Ugawa Y
Clin Neurophysiol; 2017 Jan; 128(1):31-43. PubMed ID: 27866117
[TBL] [Abstract][Full Text] [Related]
11. Heritability of saccadic eye movements in spinocerebellar ataxia type 2: insights into an endophenotype marker.
Rodríguez-Labrada R; Vázquez-Mojena Y; Canales-Ochoa N; Medrano-Montero J; Velázquez-Pérez L
Cerebellum Ataxias; 2017; 4():19. PubMed ID: 29276612
[TBL] [Abstract][Full Text] [Related]
12. Eye Movement Abnormalities Are Ubiquitous in the Spinocerebellar Ataxias.
Stephen CD; Schmahmann JD
Cerebellum; 2019 Dec; 18(6):1130-1136. PubMed ID: 31175630
[TBL] [Abstract][Full Text] [Related]
13. One‑carbon metabolism factor MTHFR variant is associated with saccade latency in Spinocerebellar Ataxia type 2.
Almaguer-Mederos LE; Jorge-Sainz Y; Almaguer-Gotay D; Aguilera-Rodríguez R; Rodríguez-Labrada R; Velázquez-Pérez L; González-Zaldívar Y; Cuello-Almarales D; Vázquez-Mojena Y; Canales-Ochoa N; Aguiar-Santiago J; Auburger G; MacLeod P
J Neurol Sci; 2020 Feb; 409():116586. PubMed ID: 31812845
[TBL] [Abstract][Full Text] [Related]
14. Impaired eye movements in presymptomatic spinocerebellar ataxia type 6.
Christova P; Anderson JH; Gomez CM
Arch Neurol; 2008 Apr; 65(4):530-6. PubMed ID: 18413478
[TBL] [Abstract][Full Text] [Related]
15. Sleep disorders in spinocerebellar ataxia type 2 patients.
Velázquez-Pérez L; Voss U; Rodríguez-Labrada R; Auburger G; Canales Ochoa N; Sánchez Cruz G; Galicia Polo L; Haro Valencia R; Aguilera Rodríguez R; Medrano Montero J; Laffita Mesa JM; Tuin I
Neurodegener Dis; 2011; 8(6):447-54. PubMed ID: 21494015
[TBL] [Abstract][Full Text] [Related]
16. Multiple saccadic abnormalities in spinocerebellar ataxia type 3 can be linked to a single deficiency in velocity feedback.
Caspi A; Zivotofsky AZ; Gordon CR
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):731-8. PubMed ID: 23249708
[TBL] [Abstract][Full Text] [Related]
17. Saccades in adult Niemann-Pick disease type C reflect frontal, brainstem, and biochemical deficits.
Abel LA; Walterfang M; Fietz M; Bowman EA; Velakoulis D
Neurology; 2009 Mar; 72(12):1083-6. PubMed ID: 19307542
[TBL] [Abstract][Full Text] [Related]
18. MRI Evidence of Cerebellar and Extraocular Muscle Atrophy Differently Contributing to Eye Movement Abnormalities in SCA2 and SCA28 Diseases.
Politi LS; Bianchi Marzoli S; Godi C; Panzeri M; Ciasca P; Brugnara G; Castaldo A; Di Bella D; Taroni F; Nanetti L; Mariotti C
Invest Ophthalmol Vis Sci; 2016 May; 57(6):2714-20. PubMed ID: 27196319
[TBL] [Abstract][Full Text] [Related]
19. Neurorehabilitation therapy in spinocerebellar ataxia type 2: A 24-week, rater-blinded, randomized, controlled trial.
Rodríguez-Díaz JC; Velázquez-Pérez L; Rodríguez Labrada R; Aguilera Rodríguez R; Laffita Pérez D; Canales Ochoa N; Medrano Montero J; Estupiñán Rodríguez A; Osorio Borjas M; Góngora Marrero M; Reynaldo Cejas L; González Zaldivar Y; Almaguer Gotay D
Mov Disord; 2018 Sep; 33(9):1481-1487. PubMed ID: 30132999
[TBL] [Abstract][Full Text] [Related]
20. Progression of early features of spinocerebellar ataxia type 2 in individuals at risk: a longitudinal study.
Velázquez-Pérez L; Rodríguez-Labrada R; Canales-Ochoa N; Montero JM; Sánchez-Cruz G; Aguilera-Rodríguez R; Almaguer-Mederos LE; Laffita-Mesa JM
Lancet Neurol; 2014 May; 13(5):482-9. PubMed ID: 24657153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
